Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
1.480
-0.010 (-0.67%)
At close: Feb 21, 2025, 4:00 PM
1.450
-0.030 (-2.03%)
After-hours: Feb 21, 2025, 4:41 PM EST
Estrella Immunopharma Market Cap
Estrella Immunopharma has a market cap or net worth of $53.55 million as of February 21, 2025. Its market cap has increased by 21.69% in one year.
Market Cap
53.55M
Enterprise Value
51.75M
1-Year Change
21.69%
Ranking
Category
Stock Price
$1.48
Market Cap Chart
Since October 19, 2022, Estrella Immunopharma's market cap has increased from $1.78M to $53.55M, an increase of 2,912.22%. That is a compound annual growth rate of 327.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 53.55M | 23.33% |
| Dec 31, 2024 | 43.41M | 11.11% |
| Dec 29, 2023 | 39.07M | 441.69% |
| Dec 30, 2022 | 7.21M | 305.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |